Strides Pharma gets tentative nod from USFDA for pain relieving drug

Strides Pharma Global Pte Ltd, Singapore, has received tentative approval for Diclofenac Potassium Softgel Capsules, 25 mg from the United States Food & Drug Administration (USFDA), Strides Pharma Science said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2sJPrJx
via IFTTT